Cavutilide (hydrochloride)
Cavutilide hydrochloride (Niferidil) is a class III antiarrhythmic agent that inhibits hERG K+ channel. Cavutilide hydrochloride has the potential for the study of persistent atrial fibrillation[1][2].
Product Specifications
CAS Number
1276021-10-3
Product Name Alternative
Niferidil
UNSPSC
12352005
Target
Potassium Channel
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Cardiovascular Disease
Smiles
O=C(C1=CC=C([N+]([O-])=O)C=C1)NC(CC2CCN(CC2)CC)C3=CC=C(C=C3)F.Cl
Molecular Formula
C22H27ClFN3O3
Molecular Weight
435.92
References & Citations
[1]WHO Drug Information, Vol. 36, No. 2, 2022.|[2]Abramochkin DV, et al. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397 (7) :5093-5104.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400026-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742853-500 1x 500 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400633-500 1x 500 µL
Von Willebrand Factor (3E2D10), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details